Aodhan James Smith, PA

Aodhan Smith practices at The Eye Physicians of Pinellas, PA in Largo, Florida.

Aodhan Smith's NPI, 1336730118, was assigned on February 3, 2021. Aodhan Smith holds Florida license PA9114016.

Aodhan Smith's primary practice is The Eye Physicians of Pinellas, PA, at 148 13th SW St, Largo, FL 33770 in Pinellas County. The practice phone is (727) 581-8706.

Aodhan Smith's primary practice is The Eye Physicians of Pinellas, PA in Largo, Florida. Dmand AI also links Aodhan Smith to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Aodhan Smith practices. Vendor and product names are available with a free account.

Physician assistant is Aodhan Smith's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Aodhan Smith is licensed in Florida.

Dmand AI lists cold sores or genital herpes, conjunctivitis and minor head injury among the conditions Aodhan Smith treats.

CMS data shows 748 Medicare services from Aodhan Smith across 9 procedure codes in 2024, for 550 Medicare patients. Medicare paid $31,833 for them. Every service was in an office.

CMS counts 550 Medicare patients who saw Aodhan Smith in 2024. The largest group is 65 to 74, with 234 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Aodhan Smith's median patient age at 73, with 63% women.

In 2024, Aodhan Smith wrote 385 Medicare Part D claims for 191 patients. 43% of them were for generic drugs. CMS names the drug for 300 of them, across 12 drugs with 11 or more claims each, at $153,869 in total drug cost.

Aodhan Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 29 general payments to Aodhan Smith from 15 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $396.